Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressive. (May 2018)

• Record Type: Journal Article
• Authors: Yun, Sanghee; Reynolds, Ryan; Petrof, Iraklis; White, Alicia; Rivera, Phillip; Segev, Amir; Gibson, Adam; Suarez, Maiko; DeSalle, Matthew; Ito, Naoki; Mukherjee, Shibani; Richardson, Devon; Kang, Catherine; Ahrens-Nicklas, Rebecca; Soler, Ivan; Chetkovich, Dane; Kourrich, Saïd; Coulter, Douglas; Eisch, Amelia
• Is Part Of: Nature medicine. Volume 24:Number 5(2018)
• Page Start: 658
• Page End: 666
• Publication Date: 2018-05
• Subjects: Pathology, Molecular -- Periodicals; Molecular biology -- Periodicals; 610.724
• DOI: 10.1038/s41591-018-0002-1
• Languages: English
• ISSNs: 1078-8956

Abstract

Abstract Major depressive disorder (MDD) is considered a 'circuitopathy', and brain stimulation therapies hold promise for ameliorating MDD symptoms, including hippocampal dysfunction. It is unknown whether stimulation of upstream hippocampal circuitry, such as the entorhinal cortex (Ent), is antidepressive, although Ent stimulation improves learning and memory in mice and humans. Here we show that molecular targeting (Ent-specific knockdown of a psychosocial stress-induced protein) and chemogenetic stimulation of Ent neurons induce antidepressive-like effects in mice. Mechanistically, we show that Ent-stimulation-induced antidepressive-like behavior relies on the generation of new hippocampal neurons. Thus, controlled stimulation of Ent hippocampal afferents is antidepressive via increased hippocampal neurogenesis. These findings emphasize the power and potential of Ent glutamatergic afferent stimulation—previously well-known for its ability to influence learning and memory—for MDD treatment. In mouse models of stress-induced depression, molecular and chemogenetic stimulation of the entorhinal cortex induces the production of adult-born hippocampal neurons and generates antidepressive-like effects.